Matinas Biopharma Holdings Current Ratio 2012-2020 | MTNB

Matinas Biopharma Holdings current ratio from 2012 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Matinas Biopharma Holdings Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-09-30 $0.07B $0.00B 22.97
2020-06-30 $0.07B $0.00B 28.74
2020-03-31 $0.07B $0.00B 29.10
2019-12-31 $0.03B $0.00B 9.66
2019-09-30 $0.03B $0.00B 13.06
2019-06-30 $0.04B $0.00B 10.81
2019-03-31 $0.04B $0.00B 12.81
2018-12-31 $0.01B $0.00B 4.61
2018-09-30 $0.01B $0.00B 2.85
2018-06-30 $0.01B $0.00B 6.27
2018-03-31 $0.01B $0.00B 4.75
2017-12-31 $0.01B $0.00B 4.50
2017-09-30 $0.01B $0.00B 5.40
2017-06-30 $0.01B $0.00B 8.79
2017-03-31 $0.02B $0.00B 8.60
2016-12-31 $0.01B $0.00B 3.16
2016-09-30 $0.01B $0.00B 4.80
2016-06-30 $0.00B $0.00B 0.58
2016-03-31 $0.00B $0.00B 1.45
2015-12-31 $0.00B $0.00B 3.15
2015-09-30 $0.01B $0.00B 5.60
2015-06-30 $0.01B $0.00B 6.06
2015-03-31 $0.01B $0.00B 3.70
2014-12-31 $0.00B $0.00B 2.51
2014-09-30 $0.01B $0.00B 5.01
2014-06-30 $0.01B $0.00B 7.67
2014-03-31 $0.01B $0.00B 12.84
2013-12-31 $0.01B $0.00B 12.72
2013-09-30 $0.01B $0.00B 25.09
2013-06-30 $0.00B 0.00
2013-03-31 $0.00B 0.00
2012-12-31 $0.00B 0.00
2012-09-30 $0.00B 0.00
2011-12-31 $0.00B $0.00B 1.33
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.213B $0.000B
Matinas BioPharma is a clinical-stage biopharmaceutical company focused on enabling the delivery of life-changing medicines using its LNC platform technology. The Company's proprietary, disruptive technology utilizes lipid nano-crystals which can encapsulate small molecule drugs, oligonucleotides, vaccines, peptides, proteins and other medicines potentially making them safer, more tolerable, less toxic and orally bioavailable. The Company's lead anti-fungal product candidate, MAT2203, utilizes its proprietary lipid nano-crystal formulation technology for the safe and effective delivery of the broad-spectrum fungicidal agent, amphotericin B. Based on the positive patient clinical data reported in 2017, Matinas is preparing for a potential Phase 2 pivotal trial of MAT2203 for prevention of invasive fungal infections in patients with acute lymphoblastic leukemia.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $68.424B 37.40
Takeda Pharmaceutical (TAK) Japan $54.984B 10.08
Astellas Pharma (ALPMY) Japan $29.658B 18.31
Eisai (ESALY) Japan $19.965B 22.15
Catalent (CTLT) United States $17.547B 46.43
Grifols, S.A (GRFS) Spain $10.602B 12.34
Jazz Pharmaceuticals (JAZZ) Ireland $9.037B 15.09
Neurocrine Biosciences (NBIX) United States $8.734B 20.25
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.586B 0.00
Ionis Pharmaceuticals (IONS) United States $7.222B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $7.220B 0.00
IPSEN SA ADR (IPSEY) France $7.154B 0.00
United Therapeutics (UTHR) United States $7.142B 13.87
Evotec AG (EVTCY) Germany $6.162B 416.11
Orion OYJ (ORINY) Finland $5.794B 20.11
Turning Point Therapeutics (TPTX) United States $5.049B 0.00
Sage Therapeutics (SAGE) United States $4.125B 0.00
Nektar Therapeutics (NKTR) United States $4.077B 0.00
PTC Therapeutics (PTCT) United States $4.070B 0.00
ChemoCentryx (CCXI) United States $3.983B 0.00
Tilray (TLRY) Canada $3.890B 0.00
Hypermarcas (HYPMY) Brazil $3.484B 13.75
Cronos Group (CRON) Canada $3.473B 0.00
Revolution Medicines (RVMD) United States $3.115B 0.00
FibroGen (FGEN) United States $3.088B 0.00
Pacira BioSciences (PCRX) United States $2.949B 49.79
Corcept Therapeutics (CORT) United States $2.798B 28.07
Taro Pharmaceutical Industries (TARO) Israel $2.705B 16.75
Xencor (XNCR) United States $2.561B 0.00
AlloVir (ALVR) United States $2.248B 0.00
USANA Health Sciences (USNA) United States $2.088B 17.09
BioCryst Pharmaceuticals (BCRX) United States $1.939B 0.00
Sundial Growers (SNDL) Canada $1.926B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.707B 0.00
ImmunoGen (IMGN) United States $1.670B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.608B 12.65
Translate Bio (TBIO) United States $1.601B 0.00
Endo (ENDP) Ireland $1.588B 2.40
Organogenesis Holdings (ORGO) United States $1.573B 0.00
Heron Therapeutics (HRTX) United States $1.549B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.448B 9.29
Ocular Therapeutix (OCUL) United States $1.315B 0.00
Indivior (INVVY) United States $1.227B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.207B 0.00
Zogenix (ZGNX) United States $1.129B 0.00
Aclaris Therapeutics (ACRS) United States $1.095B 0.00
Trillium Therapeutics (TRIL) Canada $1.056B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.005B 0.00
Radius Health (RDUS) United States $0.971B 0.00
Vectura Group (VEGPF) United Kingdom $0.952B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Aerie Pharmaceuticals (AERI) United States $0.903B 0.00
Karyopharm Therapeutics (KPTI) United States $0.865B 0.00
Esperion Therapeutics (ESPR) United States $0.767B 0.00
Collegium Pharmaceutical (COLL) United States $0.756B 28.62
Chinook Therapeutics (KDNY) United States $0.717B 0.00
VAXART, INC (VXRT) United States $0.697B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.690B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.609B 0.00
Ardelyx (ARDX) United States $0.601B 0.00
KalVista Pharmaceuticals (KALV) United States $0.566B 0.00
Flexion Therapeutics (FLXN) United States $0.566B 0.00
Molecular Templates (MTEM) United States $0.521B 0.00
Jounce Therapeutics (JNCE) United States $0.520B 0.00
Rafael Holdings (RFL) United States $0.511B 0.00
Akebia Therapeutics (AKBA) United States $0.510B 0.00
Siga Technologies (SIGA) United States $0.507B 8.40
Acutus Medical (AFIB) United States $0.496B 0.00
Altimmune (ALT) United States $0.490B 0.00
Harpoon Therapeutics (HARP) United States $0.486B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.476B 0.00
AVITA Medical (RCEL) United States $0.473B 0.00
Summit Therapeutics (SMMT) United States $0.472B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.467B 0.00
PROFOUND MEDICL (PROF) Canada $0.453B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.441B 0.00
DURECT (DRRX) United States $0.412B 0.00
TherapeuticsMD (TXMD) United States $0.390B 0.00
MEI Pharma (MEIP) United States $0.389B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.363B 9.46
Innate Pharma SA (IPHYF) France $0.356B 0.00
VYNE Therapeutics (VYNE) United States $0.343B 0.00
Nature's Sunshine Products (NATR) United States $0.337B 21.68
Redhill Biopharma (RDHL) Israel $0.312B 0.00
Alpine Immune Sciences (ALPN) United States $0.309B 0.00
CASI Pharmaceuticals (CASI) United States $0.270B 0.00
Lannett Co Inc (LCI) United States $0.250B 8.39
Xeris Pharmaceuticals (XERS) United States $0.242B 0.00
CTI BioPharma (CTIC) United States $0.223B 0.00
IMV INC (IMV) Canada $0.217B 0.00
Novan (NOVN) United States $0.207B 0.00
Oncternal Therapeutics (ONCT) United States $0.202B 0.00
Concert Pharmaceuticals (CNCE) United States $0.198B 0.00
Nutriband (NTRB) United States $0.197B 0.00
Onconova Therapeutics (ONTX) United States $0.194B 0.00
Calithera Biosciences (CALA) United States $0.190B 0.00
Jaguar Animal Health (JAGX) United States $0.190B 0.00
OptiNose (OPTN) United States $0.186B 0.00
Taiwan Liposome (TLC) Taiwan $0.182B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.182B 0.00
KemPharm (KMPH) United States $0.182B 0.00
Heat Biologics (HTBX) United States $0.181B 0.00
Infinity Pharmaceuticals (INFI) United States $0.177B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.166B 0.00
Iterum Therapeutics (ITRM) Ireland $0.165B 0.00
Qilian Holding Group (QLI) China $0.164B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.158B 0.00
Champions Oncology (CSBR) United States $0.156B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.154B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.153B 0.00
GlycoMimetics (GLYC) United States $0.153B 0.00
Aziyo Biologics (AZYO) United States $0.150B 0.00
IsoRay (ISR) United States $0.143B 0.00
Aquestive Therapeutics (AQST) United States $0.142B 0.00
MediWound (MDWD) Israel $0.141B 0.00
Genocea Biosciences (GNCA) United States $0.141B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.130B 0.00
Otonomy (OTIC) United States $0.127B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.121B 0.00
Lipocine (LPCN) United States $0.115B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.110B 0.00
Assertio Holdings (ASRT) United States $0.108B 0.00
ProPhase Labs (PRPH) United States $0.099B 0.00
SCYNEXIS (SCYX) United States $0.094B 0.00
Natural Alternatives (NAII) United States $0.092B 24.98
Aptorum Group (APM) Hong Kong, SAR China $0.090B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.089B 0.00
ElectroCore (ECOR) United States $0.089B 0.00
Recro Pharma (REPH) United States $0.086B 0.00
AIM ImmunoTech (AIM) United States $0.085B 0.00
AgeX Therapeutics (AGE) United States $0.084B 0.00
Baudax Bio (BXRX) United States $0.084B 0.00
Brickell Biotech (BBI) United States $0.077B 0.00
PolarityTE (PTE) United States $0.077B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.076B 0.00
India Globalization Capital (IGC) United States $0.074B 0.00
Sigyn Therapeutics (SIGY) United States $0.071B 0.00
Biomerica (BMRA) United States $0.069B 0.00
Addex Therapeutics (ADXN) Switzerland $0.069B 0.00
CV Sciences (CVSI) United States $0.064B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.064B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.062B 0.00
Inhibikase Therapeutics (IKT) United States $0.059B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.057B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 24.61
Plus Therapeutics (PSTV) United States $0.047B 0.00
Regulus Therapeutics (RGLS) United States $0.045B 0.00
Mannatech (MTEX) United States $0.038B 5.64
Neos Therapeutics (NEOS) United States $0.038B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.038B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.036B 0.00
RXi Pharmaceuticals (PHIO) United States $0.036B 0.00
Can-Fite Biopharma (CANF) Israel $0.028B 0.00
China SXT Pharmaceuticals (SXTC) China $0.025B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
Midatech Pharma (MTP) United Kingdom $0.024B 0.00
Cyanotech (CYAN) United States $0.022B 17.75
Bellicum Pharmaceuticals (BLCM) United States $0.019B 0.00
JanOne (JAN) United States $0.017B 0.00
HANCOCK JAFFE (HJLI) United States $0.016B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.014B 0.00
Xenetic Biosciences (XBIO) United States $0.013B 0.00
SHINECO INC (TYHT) China $0.012B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00